Youngkin's move disproportionately impacts LGBTQ community
HIV/AIDS service organizations made call on Wednesday
Apretude approved by FDA in December
Manufactured as Apretude, it will be available to at-risk adults & adolescents who weigh at least 77 pounds & have tested negative for HIV
